TotalMarketCap

Ultragenyx Pharmaceutical

RARENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.584 B

$15.55 -9.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Ultragenyx Pharmaceutical (RARE) has a market capitalization of $1.58B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$673.0M

#1740 by revenue

Earnings

-$575.0M

Loss-making

Shares outstanding

101,924,068

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #107Ani PharmaceuticalsANIP$1.60B
  2. #108SELLAS Life Sciences GroupSLS$1.59B
  3. #109Ultragenyx PharmaceuticalRARE$1.58B
  4. #110Kailera TherapeuticsKLRA$1.58B
  5. #111Braveheart BioBRVE$1.57B

What if Ultragenyx Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $28.2T

$277,038.33

Per share 17,822× higher

Bitcoin $1.53T

$14,990.06

Per share 964× higher

Apple $5.02T

$49,210.97

Per share 3,166× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Ultragenyx Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.